<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Small GTPase proteins, including RhoA, RhoB, RhoC, Rac1, and cdc42, are important molecules for linking cell shape and cell-cycle progression because of their role in both cytoskeletal arrangements and mitogenic signaling </plain></SENT>
<SENT sid="1" pm="."><plain>Over-expression of <z:mp ids='MP_0002169'>wild-type</z:mp> or constitutively active forms of RhoA has been shown to induce invasive behavior in non-invasive rat <z:e sem="disease" ids="C0019204" disease_type="Neoplastic Process" abbrv="">hepatoma</z:e> cells in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, over-expression of RhoC has been found in <z:hpo ids='HP_0002861'>melanoma</z:hpo> cells with increasing metastatic activity as well as inflammatory <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>These results indicate that overexpression of Rho proteins contributes to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Rho GDP dissociation inhibitor 2 (RhoGDI2) was recently shown to act as a <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> suppressor gene in <z:e sem="disease" ids="C0005684" disease_type="Neoplastic Process" abbrv="">bladder cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The purpose of this study was to clarify the clinical significance of this gene expression in patients with colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS: Fifty pairs of <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens obtained at the time of surgery from patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) were subjected to reverse transcription-polymerase chain reaction for RhoGDI2 </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: No patients with RhoGDI2-higher expression <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (0 in 8 cases); however, 33.3% (14 in 42 cases) of patients with RhoGDI2-lower expression <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>With regard to outcome in relation to RhoGDI2-positivity, RhoGDI2-higher expression <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had a significant correlation with superior relapse-free survival (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RFS</z:e>) time as compared to RhoGDI2-lower expression <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in stage III <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (log-rank test, P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, multivariate analysis indicated that RhoGDI2 was an independent prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RFS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: RhoGDI2 is a novel predictor of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RFS</z:e> in patients with colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>